Heterodimerization with vascular endothelial growth factor receptor-2 (VEGFR-2) is necessary for VEGFR-3 activity

被引:51
作者
Alam, A
Herault, JP
Barron, P
Favier, B
Fons, P
Delesque-Touchard, N
Senegas, I
Laboudie, P
Bonnin, J
Cassan, C
Savi, P
Ruggeri, B
Carmeliet, P
Bono, FO
Herbert, JM [1 ]
机构
[1] Sanofi Synthelabo Res, Cardiovasc Dept, Toulouse, France
[2] Cephalon Inc, W Chester, PA USA
[3] Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, Louvain, Belgium
关键词
angiogenesis; lymphanaiogenesis; CEP-5214; tyrosine kinase; VEGFR-2; VEGFR-3;
D O I
10.1016/j.bbrc.2004.08.237
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
VEGFR-3 is essential for vascular development and maintenance of lymphatic vessel's integrity. Little is known about its cooperative effect with other receptors of the same family. Contrary to VEGFR-2, stimulation of VEGFR-3 by VEGF-C and -D failed to enhance its phosphorylation either in HEK293T or in PAE cells. These ligands were unable to induce angiogenesis of PAEC expressing VEGFR-3 alone. In the presence of VEGFR-2, VEGF-C and -D induced heterodimerization of VEGFR-3 with VEGFR-2. This heterodimerization was associated with enhanced VEGFR-3 phosphorylation and subsequent cellular responses as evidenced by the formation of capillary-like structures in PAE cells and proliferation of primary human endothelial cells expressing both receptors. Taken together, these results show for the first time that VEGFR-3 needs to be associated to VEGFR-2 to induce ligand-dependent cellular responses. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:909 / 915
页数:7
相关论文
共 30 条
[1]   Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy [J].
Dias, S ;
Choy, M ;
Alitalo, K ;
Rafii, S .
BLOOD, 2002, 99 (06) :2179-2184
[2]   Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites [J].
Dixelius, J ;
Mäkinen, T ;
Wirzenius, M ;
Karkkainen, MJ ;
Wernstedt, C ;
Alitalo, K ;
Claesson-Welsh, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (42) :40973-40979
[3]   The biology of VEGF and its receptors [J].
Ferrara, N ;
Gerber, HP ;
LeCouter, J .
NATURE MEDICINE, 2003, 9 (06) :669-676
[4]   Role of tyrosine residues and protein interaction domains of SHC adaptor in VEGF Receptor 3 signaling [J].
Fournier, E ;
Blaikie, P ;
Rosnet, O ;
Margolis, B ;
Birnbaum, D ;
Borg, JP .
ONCOGENE, 1999, 18 (02) :507-514
[5]  
FOURNIER E, 1995, ONCOGENE, V11, P921
[6]   Co-expression of VEGF-C and its receptors, VEGFR-2 and VEGFR-3, in endothelial cells of lymphangioma. Implication in autocrine or paracrine regulation of lymphangioma [J].
Huang, HY ;
Ho, CC ;
Huang, PH ;
Hsu, SM .
LABORATORY INVESTIGATION, 2001, 81 (12) :1729-1734
[7]   Signaling properties of VEGF receptor-1 and-2 homo- and heterodimers [J].
Huang, K ;
Andersson, C ;
Roomans, GM ;
Ito, N ;
Claesson-Welsh, L .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (04) :315-324
[8]   Hyperplasia of lymphatic vessels in VEGF-C transgenic mice [J].
Jeltsch, M ;
Kaipainen, A ;
Joukov, V ;
Meng, XJ ;
Lakso, M ;
Rauvala, H ;
Swartz, M ;
Fukumura, D ;
Jain, RK ;
Alitalo, K .
SCIENCE, 1997, 276 (5317) :1423-1425
[9]   Vascular endothelial growth factor (VEGF)-D and VEGF-A differentially regulate KDR-mediated signaling and biological function in vascular endothelial cells [J].
Jia, HY ;
Bagherzadeh, A ;
Bicknell, R ;
Duchen, MR ;
Liu, D ;
Zachary, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (34) :36148-36157
[10]   EXPRESSION OF THE FMS-LIKE TYROSINE KINASE-4 GENE BECOMES RESTRICTED TO LYMPHATIC ENDOTHELIUM DURING DEVELOPMENT [J].
KAIPAINEN, A ;
KORHONEN, J ;
MUSTONEN, T ;
VANHINSBERGH, VWM ;
FANG, GH ;
DUMONT, D ;
BREITMAN, M ;
ALITALO, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) :3566-3570